- HHD
- Wuhan Hubei
- In Stock
- In Stock
1. Min 98%
2. Bulk in stock
3. Analysis report offer
Product Name | BAF-312(SiponiMod) |
Other Name | 1-{4-[1-((E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid |
CAS No. | 1230487-00-9 |
Appearance | White powder |
Purity | 98% |
MF | C29H35F3N2O3 |
MW | 516.59 |
Storage | Room temperature |
Shelf Life | 2 years |
Grade | Food Grade |
Siponimod is a medication that has been approved by the FDA to treat relapsing forms of multiple sclerosis, which has been defined to include relapsing remitting multiple sclerosis (RRMS), clinically isolated syndrome (CIS), and secondary progressive multiple sclerosis (SPMS) with active disease. SPMS with active disease refers to those patients who are in a progressive phase of the disease and continue to have clinical relapses.
Pharmaceutical intermediates
Every batch of our product was tested by authorized independent third party, Analysis testing center, Shanghai branch, Chinese Academy of Science. We send goods to customers with test report and COA. Our products were also tested by American Analytical Chemistry Laboratories and Chromadex too....more
